Antihypertensives Flashcards
discuss the role of diuretics in management of hypertension
- what effects do they have?
- initial effect: volume depletion
- long term effects: decrease PVR of by reducing sodium content/and decreasing senstivity of smooth muscle cells
what are the thiazides and and how can they be used to treat HTN
hydrochlorothiazide, chlorthoalidone, polythiazide, metolzode, indapamide
- monotherapy:
- thiazed can used as an initial therapy for patients with mild/moderate HTN and normal renal function
- (if renal function is impaired or the patient has heart failure, loop diuretics are better)
- thiazed can used as an initial therapy for patients with mild/moderate HTN and normal renal function
- in combination with other drugs:
- for counteracting fluid retention
what are the loop durietcs and how are they used to treat HTN?
= furosemide
- used hypertensive patients with for patients with renal dysfunction or CHF
K+ sparing diruetics
what are they and what is their role in the management of hypertension?
= spironlactone, eplerenone
- these are weaker diuretics that can can be used to counter the hypokalemic effects of other diuretics.
- (they block aldosterone and limit K+ secretion)
AES of thiazide and loop diuretics
- hyponatremia
- hypokalemia
- hypomagnesia
may increase plasma lipid, uric acid and gucose levels
what are the ACE inhibitors and ARBs
what is their role in management of hypertension?
what are their limitations?
ACE inhibitors: - prils
ARBs (AT1 receptor blockers): - sartans
-
benefitial in patients with:
- diabetes
- chronic renal disease
- HF
- patients with hyperuricemia due to diuretics
- less effective in African American patients
AEs of ACE inhibitors/ARBs
- both
- hypotension
- hypoglycemia
- hyperkalemia
- impaired renal function
- angioedema (mostly ACE inhibitors)
- just ACE inhibitors: persistent dry cough
contraindications of ACE inhibitors/ARBs
- pregnancy
- bilateral renal artery stenosis
major drug drug interactions of ACE/inhibitors & ARBS
- NSAIDS: counter their anti-hypertensive effects
- potassium sparing diuretics: together, there drugs put the patient at high risk of hyperkalemia
- lithium
MOA of calcium channel blockers
-
block smooth muscle contraction
- block Ca++ influx –> no ca++-calmodulin formation –> no myoskin light chain kinase phosphorylation –> inactivate myosin light chain
what are the two classes of calcium channel blockers used to treat HTN?
- non-dihydropyridines
- dihydropyridines
non-dydropyramids
- MOA
- list the drugs
- MOA: block contraction of cardiac muscle
- reduce SA influx into cardiac muscle, SA nodes, AV nodes
- lower CO –> lower blood pressure
- drugs:
- verapamil
- diltiazem
dihydropyridines (DHPs)
- MOA
- drugs in this class
- MOA: reduce vascular smooth muscle contraction
- reduce Ca++ influx into vascular smooth muscle cells –> lower peripheal resistance –> lower BP
- drugs: - dipines
-
long acting:
- more commonly used
- ex: amlodipine
- short acting:
- no commonly used for HTN (too many AEs)
-
long acting:
indication (s) for DHPs
hypertension in pregnant women (they are safe during pregnancy)
AES of both long and short acting DHPs
- flushing
- dizziness
- headache
- periphal edema in lower legs/hands
AEs specific to short acting DHPs
tachycardia - hence, short acting DHP rarely used to treat HTN
drug drug interactions of DHPS
- CYP - 3A4 inhibitors
- these will increase plasma concentration of DHPs – > can cause hypotension